Clicky

Oryzon Genomics SA(ORY) News

Date Title
Jun 26 ORYZON Announces Presentation of Final Data From PORTICO, Vafidemstat’s Global Phase IIb Trial in Borderline Personality Disorder, at the 37th ECNP Annual Conference
Dec 4 ORYZON Awarded with a Grant for ORY-4001 From the ALS Association in the U.S.